Varricella Infection (Candidiasis)

Overview

Varricella infection is a colloquial name used in some regions for infections caused by the yeast Candida species, most commonly Candida albicans. The medical term for these infections is candidiasis. Candida is a normal resident of the skin, mouth, gastrointestinal (GI) tract, and genital mucosa, but overgrowth can lead to symptomatic infection.

While anyone can develop candidiasis, certain groups are more susceptible:

• Women (especially for vaginal candidiasis)
• Infants and the elderly
• People with weakened immune systems (HIV/AIDS, organ transplant recipients, chemotherapy patients)
• Individuals taking broad‑spectrum antibiotics, corticosteroids, or immune‑modulating drugs
• Diabetics, especially those with poorly controlled blood glucose

Globally, CDC estimates that up to 75 % of women experience at least one episode of vaginal candidiasis in their lifetime, and oral thrush affects 5–10 % of the general population at some point. Invasive candidiasis, though less common, accounts for ~750,000 infections worldwide each year and carries a mortality rate of 30–40 % (WHO, 2022).

Symptoms

Candidiasis can manifest in many body sites. Below is a complete symptom list grouped by location.

Oral (Thrush)

• White, creamy patches on the tongue, inner cheeks, palate, or throat
• Slight burning or soreness, especially when eating or swallowing
• Loss of taste or a cotton‑mouth feeling
• Cracking at the corners of the mouth (angular cheilitis)

Vaginal (Yeast Infection)

• Intense itching, burning, or irritation of the vulva and vagina
• Thick, white, “cottage‑cheese” discharge that does not smell foul
• Redness and swelling of the vulvar tissue
• Pain during sexual intercourse or urination

Cutaneous (Skin) Candidiasis

• Red, moist, macerated patches commonly in skin folds (under breasts, groin, between fingers)
• Itching, burning, or soreness
• Satellite pustules or raised borders

Genital (Penile) Candidiasis

• Redness and rash on the glans or foreskin
• Itching, burning, or discomfort
• White, clumpy discharge under the foreskin

Invasive Candidiasis

• Fever and chills that do not improve with antibiotics
• Generalized weakness, malaise
• Abdominal pain, nausea, or vomiting if GI tract involved
• Kidney or urinary symptoms (hematuria, flank pain) in candiduria
• Signs of sepsis: rapid heart rate, low blood pressure, confusion

Causes and Risk Factors

Primary Causes

• Overgrowth of Candida yeast when the natural microbial balance is disrupted.
• Direct inoculation of Candida from colonized sites (e.g., oral‑genital transmission).
• Entry of yeast into the bloodstream via catheters, surgical wounds, or perforated mucosa.

Key Risk Factors

• Antibiotic use: Broad‑spectrum agents (e.g., clindamycin, fluoroquinolones) suppress bacterial flora, allowing yeast to proliferate.
• Hormonal changes: Pregnancy, oral contraceptives, and hormone replacement therapy increase estrogen, promoting vaginal Candida growth.
• Diabetes mellitus: Hyperglycemia provides an abundant nutrient source for yeast.
• Immunosuppression: HIV/AIDS (CD4 < 200 cells/µL), chemotherapy, corticosteroids, biologics.
• Environmental factors: Warm, moist clothing; tight underwear; prolonged use of dentures.
• Medical devices: Central venous catheters, urinary catheters, prosthetic heart valves, and intra‑abdominal drains.

Diagnosis

Accurate diagnosis depends on the infection site and severity.

Clinical Evaluation

• Physical examination of the affected area.
• Detailed medical history (antibiotic use, diabetes, immunosuppression, recent surgeries).

Laboratory Tests

• Microscopy & Gram stain: Direct visualization of budding yeast or pseudohyphae from swabs (e.g., vaginal, oral).
• Culture: Sabouraud dextrose agar or Chromogenic agar to identify Candida species and assess antifungal susceptibility.
• PCR/NAAT: Rapid detection of Candida DNA, especially useful for invasive disease.
• Blood cultures: Gold standard for candidemia; however, sensitivity is only ~50 %.
• Serum beta‑D‑glucan: Elevated levels suggest invasive fungal infection; not specific to Candida.
• Urine culture: For candiduria; important in catheter‑associated infection.

Imaging (for invasive disease)

• CT or MRI to detect abscesses in abdomen, brain, or heart valves.
• Echocardiography when endocarditis is suspected.

Treatment Options

Treatment is tailored to the site of infection, severity, and patient factors.

Topical Antifungals (Mild to Moderate Mucocutaneous Disease)

• Clotrimazole 1 % cream or pessary – 7‑day course for vaginal candidiasis.
• Miconazole 2 % cream – 7‑10 days for skin infection.
• Nystatin oral suspension – 4‑6 ml swish and swallow 4 times daily for thrush, 7‑14 days.

Systemic Antifungals (Severe or Recurrent Cases)

• Fluconazole 150 mg PO single dose or 100 mg daily for 7‑14 days (vaginal, oral, or uncomplicated urinary candidiasis).
• Itraconazole 200 mg PO BID – alternative for fluconazole‑resistant strains.
• Echinocandins (caspofungin, micafungin, anidulafungin) – IV 1‑2 mg/kg daily; first‑line for invasive candidiasis.
• Amphotericin B (liposomal) – reserved for multidrug‑resistant cases or when rapid fungicidal activity is needed.

Adjunctive Measures

• Remove or replace indwelling catheters whenever possible.
• Optimize glycemic control in diabetics (target HbA1c < 7 %).
• Probiotic supplementation (e.g., Lactobacillus rhamnosus) may help maintain vaginal flora, though evidence is mixed.

Lifestyle & Supportive Care

• Maintain good oral hygiene; clean dentures nightly.
• Keep skin folds dry; use moisture‑wicking clothing.
• Avoid douching, scented soaps, and tight-fitting underwear that disrupt normal pH.

Living with Varricella Infection (Candidiasis)

Even after successful treatment, recurrence is common. Below are practical tips for daily management.

• Track episodes: Keep a log of symptoms, triggers, and treatments to discuss with your clinician.
• Blood sugar monitoring: If diabetic, check fasting glucose daily and follow your nutrition plan.
• Dietary considerations: Limit excessive sugars and refined carbs, which may fuel yeast growth. Incorporate fermented foods (yogurt, kefir) with live cultures.
• Hygiene habits: Change out of wet clothing (swimwear, workout gear) promptly; shower after sweating.
• Medication adherence: Complete the full antifungal course even if symptoms improve early.
• Regular follow‑up: For recurrent or invasive disease, schedule periodic labs (e.g., CBC, serum beta‑D‑glucan) as instructed.
• Psychological support: Recurrent genital candidiasis can cause anxiety; consider counseling or support groups.

Prevention

Preventive strategies focus on maintaining microbial balance and reducing exposure to risk factors.

• Use antibiotics only when prescribed; discuss narrow‑spectrum options with your doctor.
• Control diabetes rigorously; monitor HbA1c at least twice a year.
• Practice safe sex; use condoms to decrease genital yeast transmission.
• Limit oral contraceptives if you have frequent yeast infections; discuss alternatives with a healthcare provider.
• Wear breathable cotton underwear; avoid tight nylon or polyester that traps moisture.
• Change diapers promptly for infants; keep the perineal area clean and dry.
• For denture wearers, remove dentures at night and disinfect them daily.
• Consider prophylactic fluconazole (100 mg weekly) for patients with recurrent (>4 episodes/year) vaginal candidiasis, after physician evaluation.

Complications

If left untreated, candidiasis can progress to serious complications.

• Invasive candidiasis: Candida can spread to bloodstream (candidemia), heart valves (endocarditis), eyes (endophthalmitis), brain (meningitis), or abdominal organs, leading to organ failure.
• Esophageal candidiasis: Causes painful swallowing, risk of esophageal ulceration and bleeding.
• Chronic urinary tract infection: Candiduria can ascend, causing pyelonephritis.
• Skin breakdown: Persistent intertriginous infection can lead to secondary bacterial cellulitis.
• Pregnancy complications: Severe vulvovaginal candidiasis may increase risk of preterm labor (observational data, CDC).

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Vulvovaginal Candidiasis. 2023. https://www.cdc.gov/fungal/diseases/candidiasis/index.html
2. Mayo Clinic. Oral Thrush. 2022. https://www.mayoclinic.org/diseases-conditions/oral-thrush
3. World Health Organization. Invasive Fungal Diseases 2022 Report. 2022.
4. Pappas PG et al. “Clinical practice guidelines for the management of candidiasis.” Clin Infect Dis. 2020;71(4): 854‑860.
5. Cleveland Clinic. Candidiasis (Yeast Infection) Overview. 2023.
6. NIH National Institute of Allergy and Infectious Diseases. Antifungal Therapy. 2021.